IMNN — Imunon Income Statement
0.000.00%
Last trade - 00:00
- $12.88m
- $3.07m
- 12
- 23
- 67
- 26
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.5 | 0.5 | 0.5 | 0.5 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 21.1 | 21.4 | 23.7 | 38.8 | 21.4 |
Operating Profit | -20.6 | -20.9 | -23.2 | -38.3 | -21.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.7 | -23.3 | -22.2 | -37.5 | -20.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.9 | -21.5 | -20.8 | -35.9 | -19.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.9 | -21.5 | -20.8 | -35.9 | -19.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.9 | -21.5 | -20.8 | -35.9 | -19.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.6 | -8.97 | -3.43 | -3.15 | -2.13 |